Browsing Over 414 Presentations

Sort By
Mini oral session 2 (ID 29) Mini oral session

Q&A (ID 799)

Lecture Time
10:50 - 10:55
Session Name
Mini oral session 2 (ID 29)
Location
Berlin Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
04.05.2019
Time
10:45 - 12:35
Multigene testing for treatment decision in early and metastatic breast cancer (ID 22) Controversy session

Second vote and conclusions (ID 62)

Lecture Time
09:20 - 09:30
Speakers
  • Fabrice André (Villejuif, France)
Session Name
Multigene testing for treatment decision in early and metastatic breast cancer (ID 22)
Location
Vienna Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
04.05.2019
Time
08:30 - 09:30
Best abstracts session (ID 44) Proffered Paper session

Session DOI (ID 865)

Lecture Time
16:45 - 16:45
Session Name
Best abstracts session (ID 44)
Location
Maritim Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
03.05.2019
Time
16:45 - 18:15
AstraZeneca - Industry Satellite Symposium: Hitting breast cancer where it hurts (ID 33) Industry Satellite Symposium

Assembling the team: A co-ordinated multidisciplinary approach (ID 744)

Lecture Time
19:10 - 19:25
Speakers
  • Christian Jackisch (Offenbach am Main, Germany)
  • Andrew Tutt (London, United Kingdom)
  • Christian F. Singer (Vienna, Austria)
  • Tjoung-Won Park-Simon (Hannover, Germany)
Session Name
AstraZeneca - Industry Satellite Symposium: Hitting breast cancer where it hurts (ID 33)
Location
Vienna Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
18:30 - 19:30
Early breast cancer: TNBC (ID 10) Educational session

TNBC: Are all tumors equal? The pathologists view (ID 23)

Lecture Time
08:45 - 09:05
Speakers
  • Carsten Denkert (Marburg, Germany)
Session Name
Early breast cancer: TNBC (ID 10)
Location
Maritim Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
03.05.2019
Time
08:45 - 10:15
Mini oral session 2 (ID 29) Mini oral session

Q&A (ID 794)

Lecture Time
11:30 - 11:35
Session Name
Mini oral session 2 (ID 29)
Location
Berlin Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
04.05.2019
Time
10:45 - 12:35
Metastatic breast cancer: HER2-/HR positive (ID 21) Educational session

When chemotherapy is required (ID 56)

Lecture Time
09:45 - 10:05
Speakers
  • Nadia Harbeck (Munich, Germany)
Session Name
Metastatic breast cancer: HER2-/HR positive (ID 21)
Location
Maritim Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
04.05.2019
Time
08:45 - 10:15
Daiichi-Sankyo - Industry Satellite Symposium: Targeting HER driven breast cancer - Emerging and future options (ID 36) Industry Satellite Symposium

Welcome & introduction (ID 827)

Lecture Time
13:00 - 13:05
Speakers
  • Fabrice André (Villejuif, France)
Session Name
Daiichi-Sankyo - Industry Satellite Symposium: Targeting HER driven breast cancer - Emerging and future options (ID 36)
Location
Vienna Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
03.05.2019
Time
13:00 - 14:00
In collaboration with ESO: Breast cancer in young women: From guidelines to clinical practice (ID 51) Special session

The biology of breast cancer in young women: What is different (ID 97)

Lecture Time
10:45 - 11:05
Speakers
  • Ann Partridge (Boston, United States of America)
Session Name
In collaboration with ESO: Breast cancer in young women: From guidelines to clinical practice (ID 51)
Location
Riga Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
03.05.2019
Time
10:45 - 12:15
In collaboration with Europa Donna (ID 53) Special session

Advocacy to ensure access and support for young women (ID 187)

Lecture Time
09:30 - 09:50
Speakers
  • Tanja Spanic (Ljubljana, Slovenia)
Session Name
In collaboration with Europa Donna (ID 53)
Location
Riga Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
04.05.2019
Time
08:45 - 10:15
Novartis - Industry Satellite Symposium: Innovation in HR+, HER2– advanced breast cancer and the emerging role of biomarkers (ID 30) Industry Satellite Symposium

The advancing role of PI3K inhibitors (ID 739)

Lecture Time
12:25 - 12:35
Speakers
  • Peter A. Fasching (Erlangen, Germany)
Session Name
Novartis - Industry Satellite Symposium: Innovation in HR+, HER2– advanced breast cancer and the emerging role of biomarkers (ID 30)
Location
Berlin Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
12:00 - 13:00
Selection of high risk /low risk patients (ID 7) Educational session

Gene profiling for risk assessment: Are they still useful? (ID 17)

Lecture Time
16:30 - 16:50
Speakers
  • Christos Sotiriou (Brussels, Belgium)
Session Name
Selection of high risk /low risk patients (ID 7)
Location
Berlin Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
16:30 - 18:00